Esterified Estrogens Combined With Methyltestosterone Raise Intraocular Pressure in Postmenopausal Women

Rahul N. Khurana, Laurie D. LaBree, Garrett Scott, Ronald E. Smith, Samuel Chi-Hung Yiu

Research output: Contribution to journalArticle

Abstract

Purpose: To investigate the effect of esterified estrogens combined with methyltestosterone (EECM) (Estratest, Solvay, Pharmaceuticals, Inc, Baudette, Minnesota, USA) on intraocular pressure (IOP) in postmenopausal women. Design: Observational case series. Methods: The IOP of 13 consecutive postmenopausal women with dry eye syndrome were recorded before and during EECM therapy (1.25 mg of esterified estrogens and 2.5 mg of methyltestosterone for several months). Results: The mean IOP increased from a baseline of 15.0 mm Hg before treatment to 18.2 mm Hg on EECM therapy (P <.0001) after a median duration of 11.3 months (range, 0.9 to 24 months). The increase in IOP was statistically significant at the 0.05 level of significance within three months and continued over 12 months. Two patients whose pressures increased (>4 mm Hg) returned to baseline levels after EECM was discontinued. Conclusions: Esterified estrogens combined with methyltestosterone produce a clinically significant increase in IOP in postmenopausal women with dry eye syndrome.

Original languageEnglish (US)
Pages (from-to)494-495
Number of pages2
JournalAmerican Journal of Ophthalmology
Volume142
Issue number3
DOIs
StatePublished - Sep 2006
Externally publishedYes

Fingerprint

Methyltestosterone
Intraocular Pressure
Estrogens
Dry Eye Syndromes
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Esterified Estrogens Combined With Methyltestosterone Raise Intraocular Pressure in Postmenopausal Women. / Khurana, Rahul N.; LaBree, Laurie D.; Scott, Garrett; Smith, Ronald E.; Yiu, Samuel Chi-Hung.

In: American Journal of Ophthalmology, Vol. 142, No. 3, 09.2006, p. 494-495.

Research output: Contribution to journalArticle

Khurana, Rahul N. ; LaBree, Laurie D. ; Scott, Garrett ; Smith, Ronald E. ; Yiu, Samuel Chi-Hung. / Esterified Estrogens Combined With Methyltestosterone Raise Intraocular Pressure in Postmenopausal Women. In: American Journal of Ophthalmology. 2006 ; Vol. 142, No. 3. pp. 494-495.
@article{cc20a5f3758d4bdbbe400ef9a76de28c,
title = "Esterified Estrogens Combined With Methyltestosterone Raise Intraocular Pressure in Postmenopausal Women",
abstract = "Purpose: To investigate the effect of esterified estrogens combined with methyltestosterone (EECM) (Estratest, Solvay, Pharmaceuticals, Inc, Baudette, Minnesota, USA) on intraocular pressure (IOP) in postmenopausal women. Design: Observational case series. Methods: The IOP of 13 consecutive postmenopausal women with dry eye syndrome were recorded before and during EECM therapy (1.25 mg of esterified estrogens and 2.5 mg of methyltestosterone for several months). Results: The mean IOP increased from a baseline of 15.0 mm Hg before treatment to 18.2 mm Hg on EECM therapy (P <.0001) after a median duration of 11.3 months (range, 0.9 to 24 months). The increase in IOP was statistically significant at the 0.05 level of significance within three months and continued over 12 months. Two patients whose pressures increased (>4 mm Hg) returned to baseline levels after EECM was discontinued. Conclusions: Esterified estrogens combined with methyltestosterone produce a clinically significant increase in IOP in postmenopausal women with dry eye syndrome.",
author = "Khurana, {Rahul N.} and LaBree, {Laurie D.} and Garrett Scott and Smith, {Ronald E.} and Yiu, {Samuel Chi-Hung}",
year = "2006",
month = "9",
doi = "10.1016/j.ajo.2006.04.018",
language = "English (US)",
volume = "142",
pages = "494--495",
journal = "American Journal of Ophthalmology",
issn = "0002-9394",
publisher = "Elsevier USA",
number = "3",

}

TY - JOUR

T1 - Esterified Estrogens Combined With Methyltestosterone Raise Intraocular Pressure in Postmenopausal Women

AU - Khurana, Rahul N.

AU - LaBree, Laurie D.

AU - Scott, Garrett

AU - Smith, Ronald E.

AU - Yiu, Samuel Chi-Hung

PY - 2006/9

Y1 - 2006/9

N2 - Purpose: To investigate the effect of esterified estrogens combined with methyltestosterone (EECM) (Estratest, Solvay, Pharmaceuticals, Inc, Baudette, Minnesota, USA) on intraocular pressure (IOP) in postmenopausal women. Design: Observational case series. Methods: The IOP of 13 consecutive postmenopausal women with dry eye syndrome were recorded before and during EECM therapy (1.25 mg of esterified estrogens and 2.5 mg of methyltestosterone for several months). Results: The mean IOP increased from a baseline of 15.0 mm Hg before treatment to 18.2 mm Hg on EECM therapy (P <.0001) after a median duration of 11.3 months (range, 0.9 to 24 months). The increase in IOP was statistically significant at the 0.05 level of significance within three months and continued over 12 months. Two patients whose pressures increased (>4 mm Hg) returned to baseline levels after EECM was discontinued. Conclusions: Esterified estrogens combined with methyltestosterone produce a clinically significant increase in IOP in postmenopausal women with dry eye syndrome.

AB - Purpose: To investigate the effect of esterified estrogens combined with methyltestosterone (EECM) (Estratest, Solvay, Pharmaceuticals, Inc, Baudette, Minnesota, USA) on intraocular pressure (IOP) in postmenopausal women. Design: Observational case series. Methods: The IOP of 13 consecutive postmenopausal women with dry eye syndrome were recorded before and during EECM therapy (1.25 mg of esterified estrogens and 2.5 mg of methyltestosterone for several months). Results: The mean IOP increased from a baseline of 15.0 mm Hg before treatment to 18.2 mm Hg on EECM therapy (P <.0001) after a median duration of 11.3 months (range, 0.9 to 24 months). The increase in IOP was statistically significant at the 0.05 level of significance within three months and continued over 12 months. Two patients whose pressures increased (>4 mm Hg) returned to baseline levels after EECM was discontinued. Conclusions: Esterified estrogens combined with methyltestosterone produce a clinically significant increase in IOP in postmenopausal women with dry eye syndrome.

UR - http://www.scopus.com/inward/record.url?scp=33748853549&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748853549&partnerID=8YFLogxK

U2 - 10.1016/j.ajo.2006.04.018

DO - 10.1016/j.ajo.2006.04.018

M3 - Article

C2 - 16935599

AN - SCOPUS:33748853549

VL - 142

SP - 494

EP - 495

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 3

ER -